Brain Navi Biotechnology
About Brain Navi Biotechnology
Brain Navi Biotechnology is a leading Taiwanese surgical robotics company that specializes in developing innovative navigation and robotic techniques for neurosurgery. Their flagship product, NaoTrac, is an autonomous neurosurgical navigation robot designed to enhance surgical precision, efficiency, and accessibility. NaoTrac utilizes Brain Navi’s patented SMART (Surface Mapping Auto-registration Technology) platform, which integrates machine vision, AI technology, and a robotic arm to provide real-time imaging, precise surgical guidance, and minimally invasive outcomes.
For physicians, NaoTrac offers several key advantages. It supports various medical imaging modalities (CT and MRI) and is applicable to procedures such as brain tumor biopsy, deep brain stimulation (DBS), stereotactic electroencephalography (SEEG), endoscopic surgery, and external ventricular drain (EVD) placements. The system features fast and precise navigation with non-contact registration, pre-operative planning, and 3D vision for accurate anatomical location. Its unique autonomous procedure allows surgeons to plan the operation while NaoTrac acts as an assistant, precisely inserting instruments into the target lesion. NaoTrac’s patient registration process uses over 100,000 checkpoints, increasing accuracy to less than 0.5mm, and its AI technology facilitates intuitive facial recognition for flexible surgical positioning, including prone positions. The system also offers non-contact movement detection, recalibrating if the surgical bed moves incidentally. NaoTrac has received CE Mark, Taiwan FDA, and U.S. FDA 510(k) clearances, and has been adopted by hospitals internationally.
Focus Areas
Business Intelligence
| Technology | SMART (Surface Mapping Auto-registration Technology) platform, machine vision, AI algorithms, robotic technology, cloud-native (implied through AI and real-time data processing) |
What Physicians Need to Know
For physicians, Brain Navi's NaoTrac offers enhanced precision and efficiency in neurosurgery, potentially reducing surgical time and improving patient outcomes. The autonomous navigation and non-contact registration simplify the surgical workflow and shorten the learning curve for new users. The compatibility with standard surgical instruments allows surgeons to utilize tools they are already familiar with. The real-time imaging and 3D visualization capabilities provide superior guidance and planning. Furthermore, the system's ability to operate in various patient positions, including prone, offers greater flexibility in the operating room. The KrystoLens disposable endoscope also addresses concerns about infection control and workflow efficiency.
Brain Navi's NaoTrac supports various medical imaging modalities, including CT and MRI, for comprehensive surgical planning. The system's architecture, as seen with its collaboration with Avalue Healthcare, utilizes high-performance computing and AI PCs for real-time AI processing and reliable operation, suggesting potential for integration with advanced hardware platforms. The open approach to surgical tool recognition also implies a degree of flexibility for integration with existing surgical instrument sets.
What the Web Says
Brain Navi Biotechnology is a Taiwanese company founded in 2015 that specializes in developing high-precision robotic surgical navigation medical devices, primarily for neurosurgery. Their flagship product, NaoTrac, is an autonomous neurosurgical navigation robot that has received CE Mark in 2021 and FDA 510(k) clearance in 2025. The company aims to improve surgical accuracy, streamline procedures, and reduce learning curves for surgeons using AI, machine vision, and robot-assisted surgery.
Overall: PositiveStrengths
- NaoTrac offers high precision and accuracy in neurosurgery.
- The system streamlines surgical procedures and can reduce surgical time.
- It has a non-contact registration feature and hands-free robotic guidance.
- NaoTrac can shorten the learning curve for surgeons.
- The technology has shown positive patient outcomes, including improved consciousness and responsiveness.
- The company has received international regulatory approvals (CE Mark, FDA 510(k)).
Limitations
- Limited public reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit specifically for Brain Navi Biotechnology.
- No specific negative product reviews were found in the search results.
- No specific negative employer reviews were found for Brain Navi Biotechnology; general 'Brain' or 'Brain Corp' reviews were not directly applicable.
Based on reviews from: Brain Navi - Surgical Robotics Technology, Brain Navi | Robotic Neurosurgery Helps a Patient Regain Hope, Brain Navi Biotechnology | Operating room Manufacturer - MedicalExpo, NaoTrac S - Brain Navi, Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac - PR Newswire, Taiwanese startup Brain Navi achieves US FDA approval for neurosurgical robot NaoTrac
Last updated: 2026-10-03
Videos
News, demos, and interviews about Brain Navi Biotechnology.
Videos load interactively. If none appear, search YouTube for Brain Navi Biotechnology →
Frequently Asked Questions
Investors
Who's funded Brain Navi Biotechnology.
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]